Home/Recalls/CANADA-75936
Health CanadaType I

JAMP-Mycophenolate 250 mg capsules: Affected lots may contain overweight or underweight capsules

Published: August 19, 2024Recall ID: 75936Category: generalCountry: Canada
Canada
Safety AlertHealth CanadaCanadaCanada

JAMP-Mycophenolate 250 mg capsules: Affected lots may contain overweight or underweight capsules

Recalling Firm: Drugs and health products

Reason for Recall / Hazard

Product safety

Product Description & Identification

If you are taking this medication, speak with your pharmacist as soon as possible. Your pharmacist will check if your product is affected by the recall and provide a replacement if needed. Given the capsule format, it is not possible to know whether your capsule is overweight or underweight by looking at it.Continue taking your medication until you speak with your pharmacist, as mycophenolate is an important drug in preventing organ rejection in kidney, heart or liver transplant patients.Contact a health care professional immediately if you or someone you are caring for experience serious side effects.Contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma.com, if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.

Affected Products

JAMP-Mycophenolate 250mg

Additional Source Details

FieldValue
N I D75936
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/jamp-mycophenolate-250-mg-capsules-affected-lots-may-contain-overweight-or-underweight
IssueProduct safety
TitleJAMP-Mycophenolate 250 mg capsules: Affected lots may contain overweight or underweight capsules
ProductJAMP-Mycophenolate 250mg
Archived0
CategoryDrugs
Last updated2024-08-19
OrganizationDrugs and health products
Recall classType I
What you should doIf you are taking this medication, speak with your pharmacist as soon as possible. Your pharmacist will check if your product is affected by the recall and provide a replacement if needed. Given the capsule format, it is not possible to know whether your capsule is overweight or underweight by looking at it.Continue taking your medication until you speak with your pharmacist, as mycophenolate is an important drug in preventing organ rejection in kidney, heart or liver transplant patients.Contact a health care professional immediately if you or someone you are caring for experience serious side effects.Contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma.com, if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.

Check Other Products In Your Household

Free Safety Tools

Safety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:

Overview

  • Recalling FirmDrugs and health products
  • Risk LevelType I
Recall Hazard Severity
Caution (Class III)
Official Agency Alert

📢 Share Warning

Alert family and friends to keep them safe. Copy this quick alert message:

🚨 SAFETY ALERT: Drugs and health products - JAMP-Mycophenolate 250 mg capsules: Affected lots may contain overweight or underweight capsules

Check if your household is affected:
https://therecallfile.com/recalls/jamp-mycophenolate-250-mg-capsules-affected-lots-may-contain-overweigh/CANADA-75936
WhatsAppFacebook

Join Alertlist

Get instant email updates whenever critical safety recalls like this are published.

Featured on Product Hunt

Help support our public safety mission and check out our community launch.

The Recall File - The Google for Product Recalls | Product Hunt

Support The Recall File

Help keep official recall alerts free, accessible, and fast for everyone.

Donate with PayPal

Supports USD, EUR, GBP, International Cards & PayPal

Spread the WordJAMP-Mycophenolate 250 mg capsules: Affected lots may contain overweight or underweight capsules

Install The Recall File App

Check safety warnings, scan your pantry, and monitor your vehicles directly from your home screen.